Companies /Healthcare

Alpha Tau Medical Ltd

NASDAQ: DRTS Biotechnology
$14.09
▲ $0.55 (+4.06%) today
Markets open · 2:15pm ET

DRTS at a Glance

Valuation
Market cap
$1.2B
Profitability
EPS (TTM)
$-1.02
Price
52-week range
$3 – $16
Street target
$17.80

Headquartered in Kiryat Hamada St. 5, Jerusalem Fiscal year ends December NASDAQ: DRTS alphatau.com

About Alpha Tau Medical

Alpha Tau Medical Ltd is a pioneering oncology therapeutics company based in Jerusalem, Israel, focused on the development and commercialization of its innovative Alpha DaRT technology. This technology is designed to treat solid tumors in various cancers, including skin, oral, pancreatic, prostate, and breast cancers, through clinical trials. Additionally, Alpha Tau Medical is exploring the potential of Alpha DaRT in preclinical studies for treating brain, liver, glioblastoma multiforme, and lung cancers, aiming to offer new hope in the fight against cancer.

Latest Activity

Reddit's most-discussed stocks · Oct 5
  1. 1DRTSbullish267 comments · 372 upvotes
  2. 2GOOGLbullish24 comments · 355 upvotes
  3. 3QQQbullish36 comments · 265 upvotes
  4. 4WULFbullish59 comments · 261 upvotes
  5. 5NVDAbearish11 comments · 170 upvotes

GOOGLheating up fast

Alpha Tau Medical is swallowing the board with 267 comments, more than every other name on today's list combined, while Alphabet chatter is heating up fast. Nvidia is the lone bearish name, and it is barely getting mentioned.

Source: Reddit

DRTS Coverage

Frequently Asked Questions

What does Alpha Tau Medical do?

Alpha Tau Medical Ltd is a pioneering oncology therapeutics company based in Jerusalem, Israel, focused on the development and commercialization of its innovative Alpha DaRT technology.

What is the DRTS stock price target?

The Wall Street consensus 12-month price target for DRTS is $17.80.